Related Experiment Video
Updated: Apr 10, 2026
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Impact of elevated cardiac biomarkers on mortality after vascular surgery procedures
Ryan Buckley1, Scott L Stevens1
1Department of Surgery, University of Tennessee School of Medicine-Knoxville, 1924 Alcoa Highway, Box U-11, Knoxville, TN 37920.
Insights
Perioperative troponin elevation in vascular surgery patients indicates poor outcomes. Higher troponin levels correlate with worse short- and long-term results, highlighting the need for early cardiac injury detection.
Area of Science:
- Cardiology
- Vascular Surgery
- Biomarkers
Background:
- Concurrent cardiac disease significantly impacts morbidity and mortality in vascular surgical patients.
- Cardiac biomarkers are increasingly utilized for identifying cardiac injury in this high-risk population.
Purpose of the Study:
- To review data on the correlation between perioperative troponin elevation and patient outcomes in vascular surgery.
- To emphasize the role of cardiac biomarkers in risk stratification and management.
Main Methods:
- Review of existing data and studies on perioperative troponin levels in vascular surgical patients.
- Analysis of the association between troponin elevation and short- and long-term clinical outcomes.
Main Results:
- Perioperative troponin elevation is demonstrably linked to adverse short- and long-term outcomes.
- Vascular surgical patients with higher circulating troponin levels exhibit poorer prognoses compared to those with lower levels.
Conclusions:
- Early identification of cardiac injury via biomarkers is crucial for vascular surgical patients.
- Biomarker-guided diagnosis, risk stratification, and aggressive medical therapy can improve outcomes.
Abstract:
Concurrent cardiac disease is an important cause of morbidity and mortality in vascular surgical patients. Increasingly, cardiac biomarkers are used to identify cardiac injury in these high-risk patients. This review provides data demonstrating that perioperative troponin elevation correlates with poor short- and long-term outcomes for vascular surgical patients. In addition, the data demonstrate that patients with high circulating troponin levels fair worse than those with lower levels. Early identification of patients with cardiac injury using biomarkers allows timely diagnosis, risk stratification, and aggressive medical therapy for vascular surgical patients.
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
01:22Aneurysm IV: Nursing Management
01:23Peripheral Artery Disease V: Postoperative Nursing Management
01:30Acute Coronary Syndrome III: Diagnostic Studies